Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations.
作者信息
Jain A B, Venkataramanan R, Cadoff E, Fung J J, Todo S, Krajack A, Starzl T E
机构信息
Department of Surgery, University of Pittsburgh, PA.
出版信息
Transplant Proc. 1990 Feb;22(1):57-9.
Abstract
摘要
相似文献
1
Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations.
Transplant Proc. 1990 Feb;22(1):57-9.
2
Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine.
Transplant Proc. 1991 Feb;23(1 Pt 2):931-3.
3
Pharmacokinetics of FK 506: preclinical and clinical studies.
Transplant Proc. 1990 Feb;22(1):52-6.
4
Effect of t-tube clamping on the pharmacokinetics of mycophenolic acid in liver transplant patients on oral therapy of mycophenolate mofetil.
Liver Transpl Surg. 1999 Mar;5(2):101-6. doi: 10.1002/lt.500050207.
5
Clinical pharmacokinetics of oral versus sublingual administration of tacrolimus in adult liver transplant recipients.
Exp Clin Transplant. 2012 Dec;10(6):586-91. doi: 10.6002/ect.2012.0032. Epub 2012 Jul 5.
6
Pharmacokinetics of FK-506, a novel immunosuppressant, after intravenous and oral administrations to rats.
J Pharmacobiodyn. 1991 Jan;14(1):34-42. doi: 10.1248/bpb1978.14.34.
7
Tacrolimus Concentrations Measured in Excreted Bile in Liver Transplant Recipients: The STABILE Study.
Clin Ther. 2018 Dec;40(12):2088-2098. doi: 10.1016/j.clinthera.2018.10.015. Epub 2018 Nov 19.
8
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.
Transplant Proc. 1990 Feb;22(1):6-12.
9
Influence of bile on cyclosporin absorption from microemulsion formulation in primary liver transplant recipients.
Transpl Int. 1995;8(4):324-6. doi: 10.1007/BF00346888.
10
The side effects of FK 506 in humans.
Transplant Proc. 1990 Feb;22(1):35-6.
引用本文的文献
1
The effects of the CYP3A5*3 variant on tacrolimus pharmacokinetics and outcomes in Tunisian kidney transplant recipients.
Tunis Med. 2023 Oct 5;101(10):738-744.
2
The impact of CYP3A4 and CYP3A5 genetic variations on tacrolimus treatment of living-donor Egyptian kidney transplanted patients.
J Clin Lab Anal. 2023 Oct;37(19-20):e24969. doi: 10.1002/jcla.24969. Epub 2023 Oct 3.
3
Sensitivity of estimated tacrolimus population pharmacokinetic profile to assumed dose timing and absorption in real-world data and simulated data.
Br J Clin Pharmacol. 2022 Jun;88(6):2863-2874. doi: 10.1111/bcp.15218. Epub 2022 Jan 27.
4
Clinically useful limited sampling strategy to estimate area under the concentration-time curve of once-daily tacrolimus in adult Japanese kidney transplant recipients.
PLoS One. 2019 Dec 11;14(12):e0225878. doi: 10.1371/journal.pone.0225878. eCollection 2019.
5
Pharmacokinetic Profile of Prolonged-Release Tacrolimus When Administered via Nasogastric Tube in De Novo Liver Transplantation: A Sub-Study of the DIAMOND Trial.
Ann Transplant. 2019 May 14;24:268-272. doi: 10.12659/AOT.909693.
6
A New CYP3A5*3 and CYP3A4*22 Cluster Influencing Tacrolimus Target Concentrations: A Population Approach.
Clin Pharmacokinet. 2017 Aug;56(8):963-975. doi: 10.1007/s40262-016-0491-3.
7
Population pharmacokinetic analysis of tacrolimus in Mexican paediatric renal transplant patients: role of CYP3A5 genotype and formulation.
Br J Clin Pharmacol. 2015 Oct;80(4):630-41. doi: 10.1111/bcp.12649. Epub 2015 Jun 22.
8
Effect of delayed CNI-based immunosuppression with Advagraf® on liver function after MELD-based liver transplantation [IMUTECT].
BMC Surg. 2014 Sep 1;14:64. doi: 10.1186/1471-2482-14-64.
9
Hepatic veno-occlusive disease resulting in tacrolimus toxicity after allogeneic hematopoietic stem cell transplantation.
Blood Res. 2013 Mar;48(1):55-7. doi: 10.5045/br.2013.48.1.55. Epub 2013 Mar 25.
10
Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients.
Br J Clin Pharmacol. 2011 Feb;71(2):207-23. doi: 10.1111/j.1365-2125.2010.03815.x.
本文引用的文献
1
Effect of bile on cyclosporin absorption in liver transplant patients.
Br J Clin Pharmacol. 1988 May;25(5):579-84. doi: 10.1111/j.1365-2125.1988.tb03348.x.
2
FK 506 for liver, kidney, and pancreas transplantation.
Lancet. 1989 Oct 28;2(8670):1000-4. doi: 10.1016/s0140-6736(89)91014-3.
3
A highly sensitive method to assay FK-506 levels in plasma.
Transplant Proc. 1987 Oct;19(5 Suppl 6):23-9.
Zotero 插件